Morgan Stanley
LBMH

Morgan Stanley’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

Morgan Stanley’s Portfolio LBMH Stock Details LBMH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-551,519
Closed -$1.84M – 6977
2015
Q4 		$1.84M Buy
551,519
+469,399
+572% +$1.36M ﹤0.01% 3572
2015
Q3 		$193K Sell
82,120
-2,488
-3% -$5.98K ﹤0.01% 5110
2015
Q2 		$192K Buy
84,608
+82,608
+4,130% +$239K ﹤0.01% 5268
2015
Q1 		$7K Sell
2,000
-63,995
-97% -$218K ﹤0.01% 6297
2014
Q4 		$191K Buy
65,995
+65,149
+7,701% +$184K ﹤0.01% 5262
2014
Q3 		$3K Sell
846
-112,768
-99% -$356K ﹤0.01% 6418
2014
Q2 		$426K Buy
113,614
+13,096
+13% +$50.9K ﹤0.01% 4700
2014
Q1 		$394K Buy
100,518
+100,218
+33,406% +$439K ﹤0.01% 4718
2013
Q4 		$1K Buy
+300
New +$1.11K ﹤0.01% 6326

Morgan Stanley's LBMH Position: Q1 2016 in Review

Morgan Stanley sold out of LIBERATOR MED HLDGS INC (NY) (LBMH) in Q1 2016, closing a stake of 551,519 shares — an estimated $1.84M sold.

Morgan Stanley first reported a position in LBMH in Q4 2013 and held it in 9 quarters. The position peaked at $1.84M in Q4 2015. 0 funds tracked by Wall St. Rank hold LBMH as of Q1 2016.

  • Morgan Stanley reported no remaining LIBERATOR MED HLDGS INC (NY) position as of Q1 2016 after selling out during the quarter.
  • Morgan Stanley sold 551,519 LIBERATOR MED HLDGS INC (NY) shares in Q1 2016, an estimated $1.84M.
  • Morgan Stanley first reported a position in LIBERATOR MED HLDGS INC (NY) in Q4 2013 and held it in 9 quarters.
  • Morgan Stanley's LIBERATOR MED HLDGS INC (NY) position peaked at $1.84M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q1 2016.

Based on Morgan Stanley's 13F filing for Q1 2016, filed 12 May 2016.